<DOC>
	<DOCNO>NCT00721981</DOCNO>
	<brief_summary>The main purpose study identification , description , segmentation non-small cell lung cancer ( NSCLC ) patient base value appraisal treatment outcome intermediate state health , obtain patient preference direct correlation clinical data patient suffer NSCLC ( stage IIIB / IV ) transition 1st 2nd line treatment , gain utility score health state derive patient ' perceive value take perspective .</brief_summary>
	<brief_title>An Evaluation Clinical Treatment Patient Values Preferences Patients Suffering From Advanced Non-small Cell Lung Cancer ( NSCLC ) Undergoing Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients suffer nonsmall cell lung cancer ( NSCLC ) clinical stage IIIB IV tumours Patients one chemotherapy regimen ( first line treatment ) ( adjuvant chemotherapy follow surgery also regard first line treatment ) Patients transition first second line treatment Patients sign informed consent Chemotherapy na√Øve patient Patients ever enrol clinical study treat nonsmall cell lung cancer ( NSCLC ) chemotherapy ( 1st 2nd line chemotherapy ) Patients ever chemotherapy indication NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>patient preference</keyword>
	<keyword>oncology</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>NSCLC</keyword>
</DOC>